(Q41455809)

30 September 2017

1 reference

title

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications (English)

1 reference

30 September 2017

1 reference

1

1 reference

30 September 2017

Venturini M

2

1 reference

30 September 2017

Sertoli MR

series ordinal

3

1 reference

30 September 2017

Rosso R

series ordinal

4

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

Breast Cancer Research and Treatment

30 September 2017

published in

1 reference

30 September 2017

volume

43

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

183-190

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1005792830054

30 September 2017

exact match

0 references

cites work

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

Adjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

Ovarian function in patients receiving adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

Analysis of survival by tumor response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

Increased risk of atherosclerosis in women after the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

Macular degeneration and early menopause: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Meeting highlights: international consensus panel on the treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Treating early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Ovarian ablation in early breast cancer: phoenix arisen?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Castration induced by cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Adjuvant chemotherapy in premenopausal patients with primary breast cancer; relation to drug-induced amenorrhoea, age and the progesterone receptor status of the tumour

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Endocrine profile in breast cancer patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Randomized cooperative study of perioperative chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Age as prognostic factor in premenopausal breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Reproductive factors and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005792830054

7 January 2021

Identifiers

DOI

10.1023/A:1005792830054

1 reference

Dimensions Publication ID

30 September 2017

1003671030

0 references

1 reference